» Articles » PMID: 38802590

Regulation of Cell Distancing in Peri-plaque Glial Nets by Plexin-B1 Affects Glial Activation and Amyloid Compaction in Alzheimer's Disease

Abstract

Communication between glial cells has a profound impact on the pathophysiology of Alzheimer's disease (AD). We reveal here that reactive astrocytes control cell distancing in peri-plaque glial nets, which restricts microglial access to amyloid deposits. This process is governed by guidance receptor Plexin-B1 (PLXNB1), a network hub gene in individuals with late-onset AD that is upregulated in plaque-associated astrocytes. Plexin-B1 deletion in a mouse AD model led to reduced number of reactive astrocytes and microglia in peri-plaque glial nets, but higher coverage of plaques by glial processes, along with transcriptional changes signifying reduced neuroinflammation. Additionally, a reduced footprint of glial nets was associated with overall lower plaque burden, a shift toward dense-core-type plaques and reduced neuritic dystrophy. Altogether, our study demonstrates that Plexin-B1 regulates peri-plaque glial net activation in AD. Relaxing glial spacing by targeting guidance receptors may present an alternative strategy to increase plaque compaction and reduce neuroinflammation in AD.

Citing Articles

Ultrafast optical imaging techniques for exploring rapid neuronal dynamics.

Nguyen T, Shalaby R, Lee E, Kim S, Ro Kim Y, Kim S Neurophotonics. 2025; 12(Suppl 1):S14608.

PMID: 40017464 PMC: 11867703. DOI: 10.1117/1.NPh.12.S1.S14608.


Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus.

Fixemer S, Miranda de la Maza M, Hammer G, Jeannelle F, Schreiner S, Gerardy J Acta Neuropathol. 2025; 149(1):19.

PMID: 39954093 PMC: 11829914. DOI: 10.1007/s00401-025-02857-8.


Antin-diabetic cognitive dysfunction effects and underpinning mechanisms of phytogenic bioactive peptides: a review.

Liu X, Mao S, Yuan Y, Wang Z, Tian Y, Tao L Front Nutr. 2025; 11:1517087.

PMID: 39867560 PMC: 11758632. DOI: 10.3389/fnut.2024.1517087.


Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease.

Xu J, Song W, Xu Z, Danziger M, Karavani E, Zang C Alzheimers Dement. 2024; 21(1):e14373.

PMID: 39641322 PMC: 11782846. DOI: 10.1002/alz.14373.

References
1.
Long J, Holtzman D . Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell. 2019; 179(2):312-339. PMC: 6778042. DOI: 10.1016/j.cell.2019.09.001. View

2.
Gandy S, DeKosky S . Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. Annu Rev Med. 2013; 64:367-83. PMC: 3625402. DOI: 10.1146/annurev-med-092611-084441. View

3.
Gandy S, Ehrlich M . Alzheimer mutant speeds APP transport. J Exp Med. 2021; 218(6). PMC: 8129791. DOI: 10.1084/jem.20210511. View

4.
Matejuk A, Ransohoff R . Crosstalk Between Astrocytes and Microglia: An Overview. Front Immunol. 2020; 11:1416. PMC: 7378357. DOI: 10.3389/fimmu.2020.01416. View

5.
Leng F, Edison P . Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?. Nat Rev Neurol. 2020; 17(3):157-172. DOI: 10.1038/s41582-020-00435-y. View